Novel low-density lipoprotein (LDL) oxidation model: Antioxidant capacity for the inhibition of LDL oxidation

被引:13
|
作者
Chu, YF
Liu, RH
机构
[1] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA
[2] Cornell Univ, Inst Comparat & Environm Toxicol, Ithaca, NY 14853 USA
关键词
low-density lipoprotein; LDL oxidation model; antioxidant; phytochemicals;
D O I
10.1021/jf040099j
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
A novel model of peroxyl radical initiated low-density lipoprotein (LDL) oxidation (LDL oxidation model for antioxidant capacity, or LOMAC) was developed to assess the free radical scavenging capacity of antioxidants and the extracts of natural products. A water-soluble free radical initiator, 2,2'-azobis-(amidinopropane) dihydrochloride, was used at physiological temperature (37 degreesC) to generate peroxyl radicals to catalyze lipid oxidation of LDL isolated from human plasma samples. Headspace hexanal, a major decomposition product of LDL oxidation, was measured by a headspace gas chromatograph as an indicator of antioxidant capacity of different concentrations of pure antioxidants (vitamins C and E) and the extracts of natural products (fresh apple phytochemical extracts). All vitamin C and E and apple extract concentrations tested resulted in increasing partial suppression and delay of LDL oxidation. On the basis of the median effective dose (EC50) calculated for each compound or extract tested, the LOMAC value of 100 g of apple against LDL oxidation was equivalent to 1470 mg of vitamin E or to 402 mg of vitamin C. This study shows that the LOMAC assay can be routinely used to analyze or screen antioxidants or phytochemical extracts against LDL oxidation to prevent cardiovascular disease. The food-specific LOMAC values will be very useful as a new alternative biomarker for future epidemiological studies of cardiovascular disease.
引用
收藏
页码:6818 / 6823
页数:6
相关论文
共 50 条
  • [31] Inhibition of low-density lipoprotein and high-density lipoprotein oxidation by raloxifene
    Resch, U
    Mellauner, V
    Budinsky, A
    Sinzinger, H
    JOURNAL OF WOMENS HEALTH, 2004, 13 (04) : 404 - 411
  • [32] Inhibition of Human Low Density Lipoprotein (LDL) Oxidation by Ginger (Zingiber officinale) Extracts: An In Vitro Study
    Gunathilake, K. D. P. P.
    Rupasinghe, H. P. Vasantha
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2012, 48 : 38 - 38
  • [33] APOPROTEIN IN STRUCTURAL ORGANIZATION OF LOW-DENSITY LIPOPROTEIN (LDL)
    TRIPLETT, RB
    WARMKE, GL
    FISHER, WR
    FEDERATION PROCEEDINGS, 1975, 34 (03) : 499 - 499
  • [34] Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein (LDL).
    Joles, JA
    Stroes, ESG
    WillekesKoolschijn, N
    Rabelink, TJ
    Koomans, HA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0340 - A0340
  • [35] PARACELLULAR MECHANISMS OF LOW-DENSITY LIPOPROTEIN (LDL) TRANSPORT
    RUTLEDGE, JC
    CURRY, FRE
    DAVIS, P
    LENZ, JF
    FASEB JOURNAL, 1988, 2 (05): : A1595 - A1595
  • [36] Oxidized low-density lipoprotein (LDL) enhances thromboxane A2 synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect
    Mahfouz, MM
    Kummerow, FA
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 62 (02): : 183 - 200
  • [37] CHOLESTEROL FEEDING AND LOW-DENSITY LIPOPROTEIN (LDL) METABOLISM
    SLATER, HR
    MCKINNEY, L
    PACKARD, CJ
    LAWRIE, TDV
    MORGAN, HG
    SHEPHERD, J
    SCOTTISH MEDICAL JOURNAL, 1983, 28 (03) : 316 - 316
  • [38] CHARGE HETEROGENEITY OF HUMAN LOW-DENSITY LIPOPROTEIN (LDL)
    GHOSH, S
    BASU, MK
    SCHWEPPE, JS
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1973, 142 (04): : 1322 - 1325
  • [39] Antioxidative activity on human low density lipoprotein (LDL) oxidation by pentagalloic acid
    Ryu B.H.
    Kim H.S.
    Moon Y.H.
    Yang S.T.
    Biotechnology and Bioprocess Engineering, 2000, 5 (5) : 366 - 371
  • [40] Dietary composition and low-density lipoprotein (LDL) modifications
    Carmena, R
    Ordovas, JM
    Ascaso, JF
    Camejo, G
    Hurt-Camejo, E
    Martinez-Valls, J
    ATHEROSCLEROSIS XI, 1998, 1155 : 507 - 517